Commonwealth Equity Services
IMUC

Commonwealth Equity Services’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Commonwealth Equity Services’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-650
Closed -$3K – 2422
2016
Q3 		$3K Sell
650
-25
-4% -$161 ﹤0.01% 2252
2016
Q2 		$6K Hold
675
– – ﹤0.01% 2229
2016
Q1 		$8K Hold
675
– – ﹤0.01% 2197
2015
Q4 		$10K Hold
675
– – ﹤0.01% 2172
2015
Q3 		$11K Buy
+675
New +$12.3K ﹤0.01% 2121

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return